Global & Public Health (all articles)
Russia tells WHO it has detected first case of avian flu strain in humans
21 Feb, 2021 | 22:08h | UTCRussia tells WHO it has detected first case of avian flu strain in humans – CNN
See also: Bird flu: Russia detects first case of H5N8 bird flu in humans – BBC AND Russia reports world’s first case of human infection with H5N8 bird flu – Reuters
The effects of tobacco control policies on global smoking prevalence
21 Feb, 2021 | 21:55h | UTCThe effects of tobacco control policies on global smoking prevalence – Nature Medicine
Commentaries on Twitter
Analysis of global #smoking prevalence trends from 2009-2017 demonstrates the effectiveness of #tobacco control policies across countries, and highlights gaps that remain for achieving universal adoption of anti-tobacco interventions. https://t.co/g86jhDUVFu #publichealth pic.twitter.com/fQZS4KKJIF
— Nature Medicine (@NatureMedicine) January 25, 2021
Nearly twice as many people live in countries (2.1 billion) where there are no smoking control or smoke-free policies, compared to people living in countries (1.1 billion) with national bans on smoking in public places.
Read more about tobacco control: https://t.co/qN8YBV9aFo pic.twitter.com/CoiOjeRFyU
— Institute for Health Metrics and Evaluation (IHME) (@IHME_UW) February 21, 2021
Opinion – Is it time to delay second doses of coronavirus vaccines?
21 Feb, 2021 | 22:39h | UTCIs it time to delay second doses of coronavirus vaccines? – CNN
3-month interval between first and second dose of Oxford COVID-19 vaccine results in higher vaccine efficacy than 6-week interval
21 Feb, 2021 | 22:42h | UTC
Opinion – Delayed second dose of the BNT162b2 vaccine: innovation or misguided conjecture?
21 Feb, 2021 | 22:38h | UTCDelayed second dose of the BNT162b2 vaccine: innovation or misguided conjecture? – The Lancet
Study: One Pfizer/BioNTech shot gives 85% Covid protection
21 Feb, 2021 | 22:41h | UTCOne Pfizer/BioNTech shot gives 85% Covid protection – study – The Guardian
Original study: Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients – The Lancet
Commentary on Twitter
NEW Correspondence reports early findings from study of #Pfizer #vaccine in health-care workers in Israel, suggesting early reductions in #COVID19 infection and symptomatic rates following first dose. Read https://t.co/ONU8bS3Iwo pic.twitter.com/BDDvA7Juyb
— The Lancet (@TheLancet) February 19, 2021
Pfizer vaccine doesn’t need ultra-cold storage after all, company says
21 Feb, 2021 | 22:37h | UTCPfizer vaccine doesn’t need ultra-cold storage after all, company says – ARS Technica
News release: PFIZER AND BIONTECH SUBMIT COVID-19 VACCINE STABILITY DATA AT STANDARD FREEZER TEMPERATURE TO THE U.S. FDA
Commentary on Twitter
🔥Pfizer BioNTech announced submission of new data to the U.S. FDA demonstrating the stability of their COVID-19 vaccine when stored at -25°C to -15°C (-13°F to 5°F), temperatures more commonly found in pharmaceutical freezers and refrigerators🔥https://t.co/egFsSe4oBB
— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) February 19, 2021
Twelve criteria for the development and use of COVID-19 vaccine passports
21 Feb, 2021 | 22:36h | UTCTwelve criteria for the development and use of COVID-19 vaccine passports – The Royal Society
Commentaries: Vaccine passports can work, but face 12 challenges – University of Oxford AND UK scientists highlight 12 criteria for Covid vaccine passports – The Guardian
See also: What place should COVID-19 vaccine passports have in society? – Ada Lovelace Institute AND WHO looks at possible ‘e-vaccination certificates’ for travel – Reuters
Coronapod: our future with an ever-present coronavirus
21 Feb, 2021 | 22:32h | UTCCoronapod: our future with an ever-present coronavirus – Nature
Long Covid: Sequelae in adults at 6 Months after COVID-19 infection
21 Feb, 2021 | 22:13h | UTCSequelae in Adults at 6 Months After COVID-19 Infection – JAMA Network Open
Commentaries: Almost a third of people with ‘mild’ COVID-19 still battle symptoms months later, study finds – CNN AND Nearly One Third of Covid-19 Survivors Have Symptoms, Some Up To 9 Months Later, New Study Finds – Forbes
Commentary on Twitter
Long COVID:
~1/3 of COVID-19 pts had lingering symptoms of a median of 6 mths after infection onset.Among pts whose infections ranged from asymptomatic to severe, 2 problems — fatigue & loss of smell/taste persisted most frequently.https://t.co/xoaWwskPnP
— Christopher Lee (@chriskc_Lee) February 20, 2021
The Lancet Commission on Global Eye Health: Vision Beyond 2020
19 Feb, 2021 | 02:38h | UTCGlobal Eye Health: vision beyond 2020 – The Lancet Global Health
Commentary on Twitter
NEW—Eliminating preventable sight loss could bring economic benefits of US$411 billion a year, unlock human potential & accelerate global development. @LancetGH #GlobalEyeHealth Commission reports on action needed now to deliver key 👁️ health services. https://t.co/aLNmwKVENB pic.twitter.com/u69JFGL2BY
— The Lancet (@TheLancet) February 17, 2021
WHO call to action: Vaccine equity declaration – We must accelerate vaccine equity for all health workers – Now
19 Feb, 2021 | 03:03h | UTCCall to Action: Vaccine Equity Declaration – World Health Organization
A single dose of the Pfizer–BioNTech vaccine is 92.6% effective in preventing Covid-19. Is delaying the second dose to get more people vaccinated an alternative?
19 Feb, 2021 | 02:59h | UTCSafety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine – New England Journal of Medicine
Commentary: Researchers urge delaying Pfizer vaccine’s second dose as first highly effective – Reuters
Covid-19: In vitro studies show Pfizer-BioNTech and Moderna vaccines produce fewer antibodies against South African variant
19 Feb, 2021 | 03:01h | UTCCommentaries: Expert reaction to two NEJM Correspondence articles on in vitro studies of the Pfizer-BioNTech and Moderna vaccines and different variants/mutations including mutations on the South Africa variant – Science Media Centre AND Lab studies suggest Pfizer, Moderna vaccines can protect against coronavirus variant – CNN AND Pfizer and Moderna vaccines have reduced effectiveness against South African variant, newly published studies show – The Washington Post AND Pfizer, Moderna vaccines less effective against South African COVID variant – MedicalXpress
Commentary on Twitter
New reports @NEJM today confirming some immune evasion of the B.1.351 variant (identified in South Africa) to both the mRNA vaccines, in vitro data @BioNTech_Group/@Pfizer and @moderna_tx. Less vaccine efficacy vs B.1.351 has been confirmed in clinical trials for 3 vaccines pic.twitter.com/2N7eKDllso
— Eric Topol (@EricTopol) February 17, 2021
Years of life lost to COVID-19 in 81 countries
19 Feb, 2021 | 02:55h | UTCYears of life lost to COVID-19 in 81 countries – Scientific Reports
News release: COVID-19: Over 20.5 million years of life may have been lost due to COVID-19
Commentaries: Expert reaction to study estimating years of life lost globally to COVID-19 – Science Media Centre AND 20.5m years of life may have been lost to Covid across 81 countries, study finds – The Guardian
What does 95% COVID-19 vaccine efficacy really mean?
19 Feb, 2021 | 02:58h | UTCWhat does 95% COVID-19 vaccine efficacy really mean? – The Lancet Infectious Diseases
Related: Pfizer vaccine: what an ‘efficacy rate above 90%’ really means – The Conversation
Fauci: There’s evidence COVID-19 vaccines don’t just protect you — they may stop you from spreading the virus to others, too
19 Feb, 2021 | 02:46h | UTCRelated: [Preprint] Covid-19 vaccination associated with reduced viral load, may reduce transmission (study and commentary)
How many people get ‘long COVID’ – and who is most at risk?
19 Feb, 2021 | 02:54h | UTCHow many people get ‘long COVID’ – and who is most at risk? – The Conversation
The price of success—how to evaluate Covid-19 vaccines when they’re available outside of clinical trials
19 Feb, 2021 | 02:43h | UTC
SR: Integrating palliative care in ambulatory care of noncancer serious chronic illness
19 Feb, 2021 | 02:28h | UTCFull report: Integrating Palliative Care in Ambulatory Care of Noncancer Serious Chronic Illness
Evidence summary: Integrating Palliative Care in Ambulatory Care of Noncancer Serious Illness
M-A: Risk factors for suicide in prisons
19 Feb, 2021 | 02:10h | UTC
Commentary on Twitter (thread – click for more)
New paper! Meta-analysis of risk factors for completed suicide in prison. Included data on >35,000 suicides, 77 studies from 27 countries. Some potentially important findings, esp. differences with risk factors in general population. #OA @TheLancetPH: https://t.co/G26576gOrH 1/ pic.twitter.com/gB7efLHkqK
— Seena Fazel (@seenafazel) February 10, 2021
AAP: 2021 Recommendations for Preventive Pediatric Health Care
18 Feb, 2021 | 03:01h | UTCRecommendations: Periodicity Schedule
Clinical decisions: Delayed second dose vs. standard regimen for Covid-19 vaccination
18 Feb, 2021 | 03:17h | UTC
World’s first coronavirus “Human Challenge” study receives ethics approval in the UK
18 Feb, 2021 | 03:14h | UTCWorld’s first coronavirus Human Challenge study receives ethics approval in the UK – GOV.UK
Commentaries: Covid-19: World’s first human trials given green light in UK – BBC AND UK to infect up to 90 healthy volunteers with Covid in world first trial – The Guardian
WHO Guidance on the subject: Feasibility, potential value and limitations of establishing a closely monitored challenge model of experimental COVID-19 infection and illness in healthy young adult volunteers – World Health Organization AND Key criteria for the ethical acceptability of COVID-19 human challenge studies – World Health Organization
See also: Challenge Trials—Could Deliberate Coronavirus Exposure Hasten Vaccine Development? – JAMA AND Ethical guidelines for deliberately infecting volunteers with COVID-19 – Journal of Medical Ethics AND Challenge trials can speed development of a Covid-19 vaccine. Planning for them needs to start now – STAT AND Accelerating Development of SARS-CoV-2 Vaccines — The Role for Controlled Human Infection Models – New England Journal of Medicine AND Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure – The Journal of Infectious Diseases AND Ethics of controlled human infection to address COVID-19 – Science AND Extraordinary diseases require extraordinary solutions – Vaccine
Open schools in Sweden during the SARS-CoV-2 pandemic were associated with low incidence of severe Covid-19 among schoolchildren and children of preschool age
18 Feb, 2021 | 03:19h | UTCOpen Schools, Covid-19, and Child and Teacher Morbidity in Sweden – New England Journal of Medicine